Effect of rituximab on the incidence of GVHD in lymphoma patients who received the BEAM-conditioning and an allogeneic stem cell transplantation.

被引：0
|
作者：
Khouri, IF [1 ]
Saliba, RM [1 ]
Couriel, DR [1 ]
Okoroji, GJ [1 ]
Acholonu, S [1 ]
Maadani, F [1 ]
Champlin, RE [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4980
引用
收藏
页码：326B / 326B
页数：1
相关论文
共 50 条
  • [21] Incidence of herpesvirus infections following nonmyeloablative allogeneic stem cell transplantation.
    Junghanss, C
    Boeckh, M
    Carter, R
    Sandmaier, BM
    Maloney, D
    Chauncey, T
    McSweeney, PA
    Corey, L
    Storb, R
    BLOOD, 2000, 96 (11) : 188A - 188A
  • [22] Effect of repeated apotransferrin administrations on serum iron parameters in patients undergoing myeloablative conditioning and allogeneic stem cell transplantation.
    Ebeling, Freja
    Parkkinen, Jaakko
    Sahlstedt, Leila
    von Bonsdorff, Leni
    Salo, Hanna
    Ruutu, Tapapi
    BLOOD, 2006, 108 (11) : 847A - 847A
  • [23] Mycophenolate mofetil and CSA as GVHD prophylaxis after allogeneic blood stem cell transplantation.
    Bornhauser, M
    Thiede, HM
    Schuler, SU
    Thiede, C
    Ehninger, G
    BONE MARROW TRANSPLANTATION, 1998, 21 : S117 - S117
  • [24] REDUCED INTENSITY CONDITIONING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR ADULTS WITH RELAPSED AND REFRACTORY MANTLE CELL LYMPHOMA IN THE RITUXIMAB ERA
    Mussetti, A.
    Devlin, S. M.
    Castro-Malaspina, H. R.
    Barker, J. N.
    Giralt, S.
    Sauter, C.
    Perales, M-A.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S171 - S172
  • [25] Zevalin and BEAM (Z-BEAM) versus rituximab and BEAM (R-BEAM) conditioning chemotherapy prior to autologous stem cell transplantation in patients with mantle cell lymphoma
    Berger, Martin D.
    Branger, Giacomo
    Klaeser, Bernd
    Taleghani, Behrouz Mansouri
    Novak, Urban
    Banz, Yara
    Mueller, Beatrice U.
    Pabst, Thomas
    HEMATOLOGICAL ONCOLOGY, 2016, 34 (03) : 133 - 139
  • [26] Outcomes of Hodgkin lymphoma patients who relapse after allogeneic stem cell transplantation
    Castagna, L.
    Sarina, B.
    Crocchiolo, R.
    Bramanti, S.
    Furst, S.
    Devillier, R.
    Coso, D.
    Bouabdallah, R.
    Mokart, D.
    Morabito, L.
    Harbi, S.
    Giordano, L.
    Rimondo, A.
    Weiller, P. Jean
    Carlo-Stella, C.
    Santoro, A.
    Chabannon, C.
    Blaise, D.
    BONE MARROW TRANSPLANTATION, 2016, 51 (12) : 1644 - 1646
  • [27] Outcomes of Hodgkin lymphoma patients who relapse after allogeneic stem cell transplantation
    L Castagna
    B Sarina
    R Crocchiolo
    S Bramanti
    S Furst
    R Devillier
    D Coso
    R Bouabdallah
    D Mokart
    L Morabito
    S Harbi
    L Giordano
    A Rimondo
    P Jean Weiller
    C Carlo-Stella
    A Santoro
    C Chabannon
    D Blaise
    Bone Marrow Transplantation, 2016, 51 : 1644 - 1646
  • [28] Allogeneic stem cell transplantation for relapsed/refractory lymphoma after conditioning with BEAM/Fludarabine/TBI - an analysis of 50 consecutive patients
    O'Meara, A.
    Halter, J.
    Heim, D.
    Gerull, S.
    Bucher, C.
    Passweg, J.
    Buser, A.
    Stern, M.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S441 - S442
  • [29] Chemokine profiling in patients with graft versus host disease (GVHD) following allogeneic blood stem cell transplantation.
    Ziegler, Judy A.
    Lokshin, Anna
    Lentzsch, Suzanne
    Agha, Mounzer
    Arnold, Renate
    Mapara, Markus Y.
    BLOOD, 2006, 108 (11) : 814A - 815A
  • [30] Graft-versus-myeloma effect following reduced intensity conditioning allogeneic stem cell transplantation.
    Mohty, M
    Boiron, JM
    Damaj, GL
    Michallet, AS
    Bay, JO
    Faucher, C
    Perreau, V
    Bilger, K
    Stoppa, A
    Tabrizi, R
    Gastaut, JA
    Michallet, M
    Maraninchi, D
    Blaise, D
    BLOOD, 2003, 102 (11) : 732A - 732A
12345